search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ARCHITECTURE & DESIGN


achieve a 23.6% reduction in regulated carbon dioxide emissions when calculated in accordance with the BREEAM 2011 Ene04 requirements, and these options were selected.


Reducing solar gains and preventing overheating The building footprint fills the site boundary in order to provide the required accommodation, so there was little option in terms of orientation. Natural light is important for health and wellbeing, and so the building is highly glazed, with glazing specified to reduce solar gains on the southern elevations. A full Part L modelling exercise was undertaken, and fritting was designed into glazing locally, to control overheating in rooms with higher volumes of glazing.


The majority of the new Cancer Centre is mechanically ventilated, with air change rates in line with HTM requirements, maintaining a minimum fresh air provision at a rate of 12 litres/second/person as required. A natural ventilation solution is provided to the main atrium and entrance areas, using the entrance doors as an air inlet, and rooflights as an exhaust air path. The lighting scheme uses low energy LED luminaires with absence detection PIRs where appropriate, while sensor taps have been specified where possible to reduce water wastage. The scheme has a below ground rainwater attenuation tank, which will retain all water on site from a 1:100 year rainwater event, plus a 30% climate change allowance.


The building has only recently handed over, and so in-use energy assessments etc. have not yet been undertaken. The scheme is still on target to achieve BREEAM Excellent, with the evidence due to be submitted to the BRE. The mechanical and electrical systems are performing as expected, so it can be anticipated that the predicted carbon reduction should also be achieved.


Procurement


Laing O’Rourke (LOR) was appointed at FBC stage as the design and build contractor following competition under a two-stage tender process using the NEC 3 Option C Target Cost form of contract. The design team of BDP and AECOM novated following completion of the outline design at RIBA stage 3. The engagement of LOR with its M&E partner, Crown House, at this stage ensured that buildability was integrated into the detailed design, and allowed the contractor to maximise the use of modern methods of construction to provide overall programme benefits and reduce the amount of vehicle movements on the surrounding road network. These included the use of a unitised fully glazed cladding system, modular M&E services, and modular concrete bunkers.


An axonometric section diagram of the new cancer facility.


During the development of the Guaranteed Maximum Price, key enabling works were undertaken to clear the site, mobilise the site establishment, and undertake groundworks to reduce the overall construction programme. The Trust worked closely with Laing O’Rourke to allow the installation of a significant amount of major medical equipment – including two linear accelerators, MRI, CT, PET CT, fluoroscopy, and X-ray machines, and a fully operational aseptic suite – prior to building handover. This reduced the post-handover commissioning period.


Key challenges


During the construction stage the project encountered a number of significant challenges which had the potential for significant delays. These included two supply chain members going into liquidation, delays to construction of the adjacent new Royal Liverpool University Hospital following the demise of Carillion, and the COVID-19 pandemic implications in March 2020 as the project was in the final completion stages.


However, with strong partnership working, and the drive and determination of the project directors from PropCare (on behalf of the Trust) and Laing O’Rourke, solutions were put in place quickly with the assistance and co- operation of the whole supply chain to mitigate the delays.


Despite the challenges, the new facility became operational two weeks early – a remarkable achievement for the whole team, and a direct result of the integrated teamwork between LOR and the PropCare/Trust project team.


Conclusion


Dr Liz Bishop, Chief Executive of The Clatterbridge Cancer Centre NHS Foundation Trust, said: “Clatterbridge Cancer Centre – Liverpool is the


culmination of an eight-year project for transforming cancer care in a region with one of the highest rates of cancer in the country. It brings state-of-the-art facilities, novel treatments, and research together to improve outcomes and save lives in Cheshire and Merseyside at a time when one in two of us will get cancer in our lifetime.


“We are tremendously excited about opening Clatterbridge Cancer Centre – Liverpool. It has been a huge labour of love, and I would like to pay tribute to our staff, the Laing O’Rourke site team, our suppliers, sub-contractors, and all the partners, who, by working together, have made this happen.”


“From a BDP standpoint (says Ged Couser), this highly glazed building will become a beacon for cancer care in Liverpool and the wider region. Its modern, sophisticated external skin is a clear expression of the cutting-edge research and care taking place within. Even in its tight urban context, the internal spaces will have access to high quality external landscape, recognising the therapeutic value this brings to patients.”


Patient and staff experience pivotal Emma Lepley, architect at BDP, the Design Team leader at the point of handover of the project, said: “The patient and staff experience was at the heart of the design process. The focus was on providing a comforting and less clinical feeling environment for patients and their families, while also designing in efficiencies for the staff, as well as places for them to rest and share ideas and research. This was achieved by working closely with focus groups throughout the whole design process, careful selection of materials, and consideration of adjacencies to make sure the building works for everyone.”


Richard Mann, AECOM UK & Ireland Healthcare and Science Sector leader,


January 2021 Health Estate Journal 27


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64